Immune system changes may drive aggressiveness of recurrent tumors
Wednesday, December 26, 2012 - 16:30
in Health & Medicine
The traditional view of recurrent tumors is that they are resistant to therapy because they’ve acquired additional genetic mutations that make them more aggressive and impervious to drugs. Now, however, researchers show in an animal model that the enhanced aggressiveness of recurrent tumors may be due to changes in the body’s immune response.